BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21631263)

  • 1. Update on precursor and early lesions of hepatocellular carcinomas.
    Park YN
    Arch Pathol Lab Med; 2011 Jun; 135(6):704-15. PubMed ID: 21631263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latest developments in precancerous lesions of hepatocellular carcinoma.
    Niu ZS; Niu XJ; Wang WH; Zhao J
    World J Gastroenterol; 2016 Mar; 22(12):3305-14. PubMed ID: 27022212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study].
    Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular dysplastic nodules.
    Roncalli M; Borzio M; Di Tommaso L
    Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver precancerous lesions and hepatocellular carcinoma: the histology report.
    Roncalli M; Terracciano L; Di Tommaso L; David E; Colombo M; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma.
    Chen D; Li Z; Zhu W; Cheng Q; Song Q; Qian L; Zhu JY
    J Clin Pathol; 2019 Apr; 72(4):295-303. PubMed ID: 30610005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes of early human hepatocarcinogenesis.
    Hytiroglou P
    Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
    Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
    Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocarcinogenesis in human liver].
    Nagy P; László V; Schaff Z
    Magy Onkol; 2006; 50(2):107-13. PubMed ID: 16888673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint.
    Kojiro M
    J Hepatobiliary Pancreat Surg; 2000; 7(6):535-41. PubMed ID: 11180884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytological characteristics of small cell change of dysplasia in small hepatic nodules.
    Chang O; Yano Y; Masuzawa A; Fukushima N; Teramura K; Hayashi Y
    Oncol Rep; 2010 May; 23(5):1229-32. PubMed ID: 20372834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preneoplastic lesions in human hepatocarcinogenesis.
    Libbrecht L; Desmet V; Roskams T
    Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.
    Park YN; Kojiro M; Di Tommaso L; Dhillon AP; Kondo F; Nakano M; Sakamoto M; Theise ND; Roncalli M
    Cancer; 2007 Mar; 109(5):915-23. PubMed ID: 17279586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions.
    Ojima H; Masugi Y; Tsujikawa H; Emoto K; Fujii-Nishimura Y; Hatano M; Kawaida M; Itano O; Kitagawa Y; Sakamoto M
    Cancer Sci; 2016 Apr; 107(4):543-50. PubMed ID: 26797961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
    Osada T; Sakamoto M; Nishibori H; Iwaya K; Matsuno Y; Muto T; Hirohashi S
    J Hepatol; 1997 Jun; 26(6):1266-73. PubMed ID: 9210613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.
    Frachon S; Gouysse G; Dumortier J; Couvelard A; Nejjari M; Mion F; Berger F; Paliard P; Boillot O; Scoazec JY
    J Hepatol; 2001 Jun; 34(6):850-7. PubMed ID: 11451168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.